Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00998_nanopub.RASrfoTjqwGVZnX0IyJ2u7iTMnIvOBrQ5_schOG3WNEg0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00998 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00998 label "DDI between Zolmitriptan and Frovatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and frovatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00998]" assertion.
- drugbank_resource:DB00315_DB00998 identifier "drugbank_resource:DB00315_DB00998" assertion.
- drugbank_resource:DB00315_DB00998 title "DDI between Zolmitriptan and Frovatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and frovatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00998 assertion.
- drugbank:DB00998 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00998 assertion.